OS Animal Health (OSAH), a wholly owned OS Therapies (OSTX) subsidiary, targets an IPO on NYSE American or Nasdaq ...

Activation of immune blood biomarkers from interferon gamma pathway distinguished long-term survivors (>=2 years) ...

This announcement contains inside information as defined in the UK version of the Market Abuse Regulation (EU) No.596/2014, ...

While the accounts won't officially launch for a few months, you can start the application process now.